| Biomarker ID | 241 |
| PMID | 18190830 |
| Year | 2007 |
| Biomarker | Chitotriosidase |
| Biomarker Basis | Concentration Based (mmol/ml·h) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa (PCa: 91.33 ± 8.32 Vs BPH: 69.72 ±8.69) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- Amino sugar and nucleotide sugar metabolism,Prolactin regulation of apoptosis |
| Experiment | Normal (Control) Vs Cancer (High Gleason Grade) |
| Type of Biomarker | Diagnostic |
| Cohort | Serum samples from 93 patients with primary prostate cancer, 61 with prostatic hyperplasia, and 56 controls were compared. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Fluorometer |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | CHIT1 |